Serum Hepcidin in Inflammatory Bowel Diseases: Biological and Clinical Significance
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hepcidin, a peptide produced by hepatocytes, regulates body iron homeostasis. Inflammation increases serum hepcidin, and its determination can be useful in the differential diagnosis of anemias during inflammatory diseases. METHODS: We measured serum hepcidin-25 and hepcidin-20 isoforms in 54 patients with inflammatory bowel diseases (IBD) and 54 reference subjects (36 healthy controls and 18 anemic patients without inflammation or renal failure). Disease activity, blood counts, iron status, and erythropoiesis-related parameters were obtained for all study subjects. RESULTS: In IBD hepcidin-25, the peptide bioactive isoform correlated positively with C-reactive protein and serum ferritin; an inverse correlation was observed with transferrin, the soluble transferrin receptor, and the soluble transferrin receptor to Log(ferritin) ratio. Similar correlations were found in reference subjects. Patients with anemia of inflammation had higher hepcidin-25 levels than those with iron deficiency anemia or a combination of iron deficiency anemia and inflammation (P = 0.0061). In patients with inflammation and serum ferritin concentration 100 to 200 ng/mL, hepcidin-25 was low, suggesting that these patients had iron deficiency. A serum hepcidin-25 concentration below 2.0 nM differentiated 85% of patients with iron deficiency anemia (with or without inflammation) from patients with anemia of inflammation. In IBD, hepcidin-20 correlated with both hepcidin-25 and C-reactive protein. CONCLUSIONS: In IBD, iron stores, inflammation, and iron requirement for erythropoiesis influence serum hepcidin-25. Hepcidin-25 determination can be useful in the differential diagnosis of IBD-associated anemias. Serum hepcidin-20 is linked to hepcidin-25, but inflammation has an independent regulatory role on its concentration, indicating that hepcidin-20 may have a biological function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, HAMP is suppressed in IDA, in the normal range in IDA/AI, and elevated in AI [112, 118].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120 · cited 2×
“transferrin saturation, infection, and inflammation induce it.(8,9) Hepcidin behaves like a type II acute-phase reactant.”
BackgroundHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417 · cited 1×
“Hepcidin behaves like a type II acute-phase reactant.(10) Hepcidin induction during inflammation decreases iron availability to invading pathogens and reduces iron-mediated oxidative stress(11); this, however, impairs iron metabolism and contributes to the anemia of chronic disease or anemia of inflammation.”
BackgroundRachmilewitz, D. (1989) · BMJ · doi:10.1136/bmj.298.6666.82 · Cited by 1,039
Hepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962 · cited 2×
“transferrin saturation, infection, and inflammation induce it.(8,9) Hepcidin behaves like a type II acute-phase reactant.”
BackgroundSerum Transferrin Receptor and Its Ratio to Serum Ferritin in the Diagnosis of Iron Deficiency
Punnonen, K., Irjala, K., & Rajamäki, A. (1997) · Blood · doi:10.1182/blood.v89.3.1052 · Cited by 859 · cited 1×
“These parameters are believed to reflect iron status and iron supply to erythropoiesis even in the presence of inflammation.(17,18) A validated method using surface-enhanced laser desorption/ ionization time-of-flight mass spectrometry measured serum hepcidin isoforms (hepcidin-25 and hepcidin-20), as described with r…”
MethodHepcidin and the iron-infection axis
Drakesmith, H., & Prentice, A. M. (2012) · Science · doi:10.1126/science.1224577 · Cited by 686
Biochemical Markers and Hematologic Indices in the Diagnosis of Functional Iron Deficiency
Thomas, C., & Thomas, L. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.7.1066 · Cited by 492
Theurl, I., Aigner, E., Theurl, M., Nairz, M., Seifert, M., Schroll, A., Sonnweber, T., Eberwein, L., Witcher, D. R., Murphy, A. T., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195651 · Cited by 421
Serum hepcidin: reference ranges and biochemical correlates in the general population
Galesloot, T. E., Vermeulen, S. H., Geurts-Moespot, A. J., Klaver, S. M., Kroot, J. J., van Tienoven, D., Wetzels, J. F. M., Kiemeney, L. A. L. M., Sweep, F. C., den Heijer, M., et al. (2011) · Blood · doi:10.1182/blood-2011-02-337907 · Cited by 303
Wells, C. W., Lewis, S., Barton, R. J., & Corbett, S. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000196646.64615.db · Cited by 286
Immunochemical and Mass-Spectrometry–Based Serum Hepcidin Assays for Iron Metabolism Disorders
Kroot, J. J., Laarakkers, C. M., Geurts-Moespot, A. J., Grebenchtchikov, N., Pickkers, P., van Ede, A. E., Peters, H. P., van Dongen-Lases, E., Wetzels, J. F., Sweep, F. C., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.149187 · Cited by 196
Theurl, I., Mattle, V., Seifert, M., Mariani, M., Marth, C., & Weiss, G. (2006) · Blood · doi:10.1182/blood-2005-08-3364 · Cited by 188 · cited 1×
“These parameters are believed to reflect iron status and iron supply to erythropoiesis even in the presence of inflammation.(17,18) A validated method using surface-enhanced laser desorption/ ionization time-of-flight mass spectrometry measured serum hepcidin isoforms (hepcidin-25 and hepcidin-20), as described with r…”
MethodSemrin, G., Fishman, D. S., Bousvaros, A., Zholudev, A., Saunders, A. C., Correia, C. E., Nemeth, E., Grand, R. J., & Weinstein, D. A. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235097.86360.04 · Cited by 182
Kroot, J. J. C., Kemna, E. H. J. M., Bansal, S. S., Busbridge, M., Campostrini, N., Girelli, D., Hider, R. C., Koliaraki, V., Mamalaki, A., Olbina, G., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.010322 · Cited by 177
Self-citationBergamaschi, G., Di Sabatino, A., Albertini, R., Ardizzone, S., Biancheri, P., Bonetti, E., Cassinotti, A., Cazzola, P., Markopoulos, K., Massari, A., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.009985 · Cited by 167
Self-citationTraglia, M., Girelli, D., Biino, G., Campostrini, N., Corbella, M., Sala, C., Masciullo, C., Viganò, F., Buetti, I., Pistis, G., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100061 · Cited by 97
Self-citationDiagnosing anemia in inflammatory bowel disease: Beyond the established markers
Oustamanolakis, P., Κoutroubakis, I. E., & Kouroumalis, E. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.03.010 · Cited by 96
Maisetta, G., Petruzzelli, R., Brancatisano, F. L., Esin, S., Vitali, A., Campa, M., & Batoni, G. (2010) · Peptides · doi:10.1016/j.peptides.2010.08.007 · Cited by 91
Hepcidin is a key mediator of anemia of inflammation in Crohn's disease
Basseri, R. J., Nemeth, E., Vassilaki, M. E., Basseri, B., Enayati, P., Shaye, O., Bourikas, L. A., Ganz, T., & Papadakis, K. A. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.10.013 · Cited by 81
Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease
Oustamanolakis, P., Koutroubakis, I. E., Messaritakis, I., Malliaraki, N., Sfiridaki, A., & Kouroumalis, E. A. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328343b885 · Cited by 77
Theurl, I., Schroll, A., Nairz, M., Seifert, M., Theurl, M., Sonnweber, T., Kulaksiz, H., & Weiss, G. (2011) · Haematologica · doi:10.3324/haematol.2011.048926 · Cited by 76
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis
Bozzini, C., Campostrini, N., Trombini, P., Nemeth, E., Castagna, A., Tenuti, I., Corrocher, R., Camaschella, C., Ganz, T., Olivieri, O., et al. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.10.001 · Cited by 66
Self-citationThe bone morphogenetic protein–hepcidin axis as a therapeutic target in inflammatory bowel disease
Wang, L., Trebicka, E., Fu, Y., Ellenbogen, S., Hong, C. C., Babitt, J. L., Lin, H. Y., & Cherayil, B. J. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21675 · Cited by 64
Preparation and Characterization of a Novel Skin Substitute
Castagnoli, C., Fumagalli, M., Alotto, D., Cambieri, I., Casarin, S., Ostorero, A., Casimiri, R., Germano, P., Pezzuto, C., & Stella, M. (2010) · BioMed Research International · doi:10.1155/2010/840363 · Cited by 61
Ott, C., Liebold, A., Takses, A., Strauch, U. G., & Obermeier, F. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/595970 · Cited by 61
Darshan, D., Frazer, D. M., Wilkins, S. J., & Anderson, G. J. (2010) · Haematologica · doi:10.3324/haematol.2010.022426 · Cited by 61
Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis
Arnold, J., Sangwaiya, A., Bhatkal, B., Geoghegan, F., & Busbridge, M. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32830e2885 · Cited by 53
Tavanti, A., Maisetta, G., Gaudio, G. D., Petruzzelli, R., Sanguinetti, M., Batoni, G., & Senesi, S. (2011) · Peptides · doi:10.1016/j.peptides.2011.10.012 · Cited by 48
Cherayil, B. J., Ellenbogen, S., & Shanmugam, N. N. (2011) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834a4cd1 · Cited by 45
Campostrini, N., Castagna, A., Zaninotto, F., Bedogna, V., Tessitore, N., Poli, A., Martinelli, N., Lupo, A., Olivieri, O., & Girelli, D. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/329646 · Cited by 39
Self-citationSerum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study
Campostrini, N., Traglia, M., Martinelli, N., Corbella, M., Cocca, M., Manna, D., Castagna, A., Masciullo, C., Silvestri, L., Olivieri, O., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.08.006 · Cited by 31
Self-citationAnemia in Heart Failure: Association of Hepcidin Levels to Iron Deficiency in Stable Outpatients
Weber, C. S., Neto, L. B. D. S., Goldraich, L. A., Biolo, A., & Clausell, N. (2012) · Acta Haematologica · doi:10.1159/000342110 · Cited by 28
Intravenous Iron in Inflammatory Bowel Disease
Gasché, C., & Kulnigg, S. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2006.08.010 · Cited by 21
Research works printed but not linked: 1
- Blanc B, Finch CA, Hallberg L, et al. Nutritional anaemias. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser. 1968;405:1-40.
Cited by
Hepcidin in the diagnosis of iron disorders
Girelli, D., Nemeth, E., & Swinkels, D. W. (2016) · Blood · doi:10.1182/blood-2015-12-639112 · Cited by 417
Self-citationModern iron replacement therapy: clinical and pathophysiological insights
Girelli, D., Ugolini, S., Busti, F., Marchi, G., & Castagna, A. (2018) · International Journal of Hematology · doi:10.1007/s12185-017-2373-3 · Cited by 188
Self-citationAnemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy
Busti, F., Marchi, G., Ugolini, S., Castagna, A., & Girelli, D. (2018) · Pharmaceuticals · doi:10.3390/ph11040094 · Cited by 165
Self-citationNairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
Biology of Anemia: A Public Health Perspective
Brittenham, G. M., Moir-Meyer, G., Abuga, K. M., Datta-Mitra, A., Cerami, C., Green, R., Pasricha, S., & Atkinson, S. H. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.07.018 · Cited by 158
Metadata
- Authors
- Bergamaschi, G., Di Sabatino, A., Albertini, R., Costanzo, F., Guerci, M., Masotti, M., Pasini, A., Massari, A., Campostrini, N., Corbella, M., Girelli, D., & Corazza, G. R.
- Affiliations
- University of Pavia (IT)
- Policlinico San Matteo Fondazione (IT)
- University of Verona (IT)
- ORCID
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09
- Volume
- 19
- Issue
- 10
- Pages
- 2166-2172
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2021053299
- Cited by
- 56
- References
- 37
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 6 · 2021: 2 · 2020: 6 · 2019: 4 · 2018: 8 · 2017: 6 · 2016: 5 · 2015: 4 · 2014: 6
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- hepcidin, inflammatory bowel disease
- MeSH terms
- Adult, Anemia, Colitis, Ulcerative, Crohn Disease, Female, Follow-Up Studies, Humans, Inflammation, Male, Middle Aged, Prognosis, Biomarkers, Case-Control Studies, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.